Review of the Metabolic Risk Factors for Increased Severity of Coronavirus Disease-2019

被引：8

作者：

Fishkin, Tzvi ^{[1
]}

Goldberg, Michael D. ^{[2
]}

Frishman, William H. ^{[3
,4
]}

机构：

[1] Westchester Med Ctr, Dept Med, Valhalla, NY USA

[2] New York Med Coll, Dept Med, Div Endocrinol, Westchester Med Ctr, Valhalla, NY 10595 USA

[3] New York Med Coll, Dept Med, Westchester Med Ctr, Valhalla, NY 10595 USA

[4] New York Med Coll, Dept Cardiol, Westchester Med Ctr, Valhalla, NY 10595 USA

来源：

CARDIOLOGY IN REVIEW | 2021年 / 29卷 / 06期

关键词：

coronavirus; 2019; metabolic risk; UNITED-STATES; COVID-19; OUTCOMES; PREVALENCE;

D O I：

10.1097/CRD.0000000000000408

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The coronavirus 2019 (COVID-19) pandemic has presented many new challenges to the healthcare community with the sheer number of individuals affected and the range of symptoms at presentation. Early findings have shown that increased age is an independent risk factor for COVID-19 severity. Diabetes and hypertension were also found to be strong independent risk factors for severe COVID-19. It was later discovered that obesity is a strong risk factor for severe disease as well. Possible mechanisms for the increased risk associated with metabolic disease include the increased prevalence of acute respiratory syndrome, immune cell dysfunction, and chronic inflammatory states associated with obesity and diabetes. Acknowledging these risk factors has consequences for addressing vaccination strategies as well as healthcare disparities.

引用

收藏

页码：292 / 295

页数：4

相关论文

共 30 条

[1] COVID-19: Impact of obesity and diabetes on disease severity [J].

Al-Sabah, Salman ;

Al-Haddad, Mohannad ;

Al-Youha, Sarah ;

Jamal, Mohammad ;

Almazeedi, Sulaiman .

CLINICAL OBESITY, 2020, 10 (06)

[2] SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection [J].

Altmann, Daniel M. ;

Boyton, Rosemary J. .

SCIENCE IMMUNOLOGY, 2020, 5 (49)

[3]

[Anonymous], 2020, JAMA-J AM MED ASSOC, DOI DOI 10.1001/JAMA.2020.6775

[4]

Centers for Disease Control and Prevention, 2020, COVIDView: a weekly surveillance summary of U.S. COVID-19 activity

[5] Clinical Outcomes in Young US Adults Hospitalized With COVID-19 [J].

Cunningham, Jonathan W. ;

Vaduganathan, Muthiah ;

Claggett, Brian L. ;

Jering, Karola S. ;

Bhatt, Ankeet S. ;

Rosenthal, Ning ;

Solomon, Scott D. .

JAMA INTERNAL MEDICINE, 2021, 181 (03) :379-381

[6] Obesity Is a Risk Factor for Greater COVID-19 Severity [J].

Gao, Feng ;

Zheng, Kenneth I. ;

Wang, Xiao-Bo ;

Sun, Qing-Feng ;

Pan, Ke-Hua ;

Wang, Ting-Yao ;

Chen, Yong-Ping ;

Targher, Giovanni ;

Byrne, Christopher D. ;

George, Jacob ;

Zheng, Ming-Hua .

DIABETES CARE, 2020, 43 (07) :E72-E74

[7] Body mass index is associated with the development of acute respiratory distress syndrome [J].

Gong, M. N. ;

Bajwa, E. K. ;

Thompson, B. T. ;

Christiani, D. C. .

THORAX, 2010, 65 (01) :44-50

[8] Differences in Obesity Prevalence by Demographic Characteristics and Urbanization Level Among Adults in the United States, 2013-2016 [J].

Hales, Craig M. ;

Fryar, Cheryl D. ;

Carroll, Margaret D. ;

Freedman, David S. ;

Aoki, Yutaka ;

Ogden, Cynthia L. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (23) :2419-2429

[9] Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom [J].

Hamer, Mark ;

Gale, Catharine R. ;

Kivimaki, Mika ;

Batty, G. David .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (35) :21011-21013

[10] Insulin Inhibits IL-10-Mediated Regulatory T Cell Function: Implications for Obesity [J].

Han, Jonathan M. ;

Patterson, Scott J. ;

Speck, Madeleine ;

Ehses, Jan A. ;

Levings, Megan K. .

JOURNAL OF IMMUNOLOGY, 2014, 192 (02) :623-629